Published in Contact Dermatitis on April 01, 2001
Patterns of physical activity among 11 to 16 year old British children. BMJ (1990) 2.75
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia (2011) 1.76
Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol (2000) 1.76
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
Skin disorders in amputees. J Am Acad Dermatol (2000) 1.65
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol (2002) 1.52
The evidence base for the cost effectiveness of cardiac rehabilitation. Heart (1997) 1.50
High and low exercisers among 14- and 15-year-old children. J Public Health Med (1994) 1.49
Cervical spinal cord injuries without radiographic evidence of trauma: a prospective study. Spinal Cord (2013) 1.43
Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01) Br J Dermatol (2000) 1.43
Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis. Br J Dermatol (2010) 1.42
Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol (1998) 1.41
The neurotoxicity of inhaled toluene. Can J Psychiatry (1990) 1.41
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol (2005) 1.40
An audit to identify the optimum referral rate to a contact dermatitis investigation unit. Br J Dermatol (1999) 1.38
Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis. J Clin Pathol (1993) 1.38
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol (2002) 1.27
Secondary syphilis with framboesiform facial lesions: a case report. Br J Vener Dis (1981) 1.24
Extensive nevus comedonicus. Arch Dermatol (1980) 1.16
Surveillance of occupational skin disease: EPIDERM and OPRA. Br J Dermatol (2000) 1.15
Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) (2000) 1.15
Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol (2000) 1.13
The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol (2000) 1.10
Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res (2002) 1.09
Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry (1991) 1.08
Circulating natural killer cells in psoriasis. Br J Dermatol (2003) 1.04
The assessment of recovery in patients after myocardial infarction using three generic quality-of-life measures. J Cardiopulm Rehabil (1998) 1.04
Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat (2001) 1.03
IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol (2003) 1.03
The peak oxygen uptake of British children with reference to age, sex and sexual maturity. Eur J Appl Physiol Occup Physiol (1991) 1.03
Type I allergic reaction to hyaluronidase during ophthalmic surgery. Contact Dermatitis (2001) 0.99
Cytokine gene polymorphisms in psoriasis. Br J Dermatol (2001) 0.96
Allergic contact dermatitis to epichlorhydrin in a solvent cement. Contact Dermatitis (1983) 0.96
Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury. Neuroreport (2001) 0.95
Figurate erythema with bullous pemphigoid: a true paraneoplastic phenomenon? Clin Exp Dermatol (1999) 0.94
Progesterone-induced urticaria--need it be autoimmune? Br J Dermatol (1995) 0.93
Recognition, diagnosis and management of obesity after myocardial infarction. Int J Obes (Lond) (2005) 0.92
Phaeohyphomycosis caused by Exophiala salmonis. Br J Dermatol (2006) 0.92
Eczéma craquelé resulting from acute oedema: a report of seven cases. Br J Dermatol (2001) 0.92
In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. Rev Infect Dis (1989) 0.92
Patch testing to detect corticosteroid allergy: is it adequate? Contact Dermatitis (1997) 0.91
Screening for corticosteroid contact hypersensitivity. Contact Dermatitis (1995) 0.91
Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. Br J Dermatol (2005) 0.91
Accutracker II (version 30/23) ambulatory blood pressure monitor: clinical validation using the British Hypertension Society and Association for the Advancement of Medical Instrumentation standards. J Hypertens (1993) 0.89
Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. Br J Dermatol (1999) 0.89
Exogenous interleukin-1beta restores impaired Langerhans cell migration in aged skin. Br J Dermatol (2004) 0.89
Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis. Br J Dermatol (2002) 0.87
Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol (2002) 0.87
Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo. Contact Dermatitis (1998) 0.86
Body mass index, waist circumference and HOMA-IR correlate with the Psoriasis Area and Severity Index in patients with psoriasis receiving phototherapy. Br J Dermatol (2014) 0.86
The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr Dermatol (2007) 0.86
Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol (2004) 0.86
Estimation of coronary risk factors in British schoolchildren: a preliminary report. Br J Sports Med (1990) 0.85
Natural killer cells in psoriasis. J Innate Immun (2011) 0.85
Trigeminal trophic syndrome: successful treatment with carbamazepine. Br J Dermatol (1999) 0.84
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study. J Eur Acad Dermatol Venereol (2012) 0.84
Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed) (1983) 0.84
Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate. Br J Radiol (1988) 0.84
Allergic contact dermatitis from Machaerium scleroxylum Tul. (Pao ferro) in a joinery shop. Clin Exp Dermatol (1984) 0.84
Ammonium persulphate sensitivity in hairdressers. Contact Dermatitis (1985) 0.83
Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study. Clin Exp Dermatol (2011) 0.83
Sitagliptin for severe psoriasis. Clin Exp Dermatol (2014) 0.82
Serum lipids and blood pressure in relation to age and sexual maturity. Ann Hum Biol (1992) 0.82
Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis (1996) 0.82
Allergic contact dermatitis from latex rubber. Br J Dermatol (1996) 0.82
Allergic contact dermatitis from an anthraquinone derivative in a chemical plant. Contact Dermatitis (1994) 0.81
Drug survival of fumaric acid esters for psoriasis: a retrospective study. Br J Dermatol (2014) 0.81
Spa pool dermatitis. Contact Dermatitis (1995) 0.81
Asthma, hay fever and eczema in Irish teenagers (ISAAC protocol). Ir Med J (1997) 0.81
Complete skin examination is essential in the assessment of dermatology patients: findings from 483 patients. Br J Dermatol (2011) 0.81
Treatment of acrodermatitis continua of Hallopeau with adalimumab. Br J Dermatol (2008) 0.81
Liraglutide in combination with acitretin for severe recalcitrant psoriasis. Br J Dermatol (2013) 0.81
Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress. Br J Dermatol (2011) 0.81
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. Br J Dermatol (1999) 0.81
Occupational allergic contact dermatitis from triphenyl phosphite. Contact Dermatitis (1989) 0.81
Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis (1991) 0.81
Severe erythema multiforme complicated by fatal gastrointestinal involvement following co-trimoxazole therapy. Clin Exp Dermatol (1979) 0.80
Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol (1999) 0.80
Incidence by occupation and industry of work-related skin diseases in the United Kingdom, 1996-2001. Occup Med (Lond) (2006) 0.80
Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis. Clin Nephrol (1994) 0.80
Contact dermatitis from 2-n-octyl-4-isothiazolin-3-one in a PhD student. Contact Dermatitis (2004) 0.80
Allergic contact dermatitis to crystal violet lactone [corrected] in carbonless copy paper. Contact Dermatitis (1987) 0.80
Resolution of skin lesions and long-term survival in a dog with superficial necrolytic dermatitis and liver cirrhosis. J Small Anim Pract (2000) 0.79
A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Exp Dermatol (2003) 0.79
GMDP and psoriasis. Lancet (1998) 0.79
Toxicodendron dermatitis in the UK. Int J Dermatol (2006) 0.79
Intolerance and contact allergy to tar and dithranol in psoriasis. Contact Dermatitis (1994) 0.79
Past pets and Paget's disease. Lancet (1985) 0.79
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis. Clin Exp Dermatol (2009) 0.79
Contact sensitivity to octyldodecanol and trometamol in an anti-itch cream. Contact Dermatitis (2007) 0.78
Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. Br Med J (Clin Res Ed) (1985) 0.78
The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol (2007) 0.78
Treatment of lichen planus of the penis with photodynamic therapy. Br J Dermatol (1999) 0.78
The significance of positive patch tests to 17-hydroxyprogesterone. Contact Dermatitis (1994) 0.78
Solvent abuse psychosis. Br J Psychiatry (1989) 0.78
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol (2012) 0.78
Lymphocyte transformation and thiuram sensitization. Contact Dermatitis (1991) 0.78